Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease

Clinical trial NCT04151225 · WITHDRAWN

Trial details

NCT number: NCT04151225
Sponsor: GlaxoSmithKline
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Crohns Disease Crohn's Disease

Start date: 2021-04-05
Primary completion: 2024-04-22
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.